Late-stage French biotech developing therapies for chronic inflammatory diseases.
Industry: Health Care
Latest Trade: $9.78 0.00 (0.0%)
First Day Return: -28.4%
Return from IPO: -15.7%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/29/2023 |
Offer Price | $11.60 |
Price Range $11.60 - $13.00 | |
Offer Shares (mm) | 20.3 |
Deal Size ($mm) | $236 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 10/19/2023 |
Offer Price | $11.60 |
Price Range $11.60 - $13.00 | |
Offer Shares (mm) | 20.3 |
Deal Size ($mm) | $236 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Morgan Stanley |
Leerink Partners |
more |
Company Data | |
---|---|
Headquarters | Paris, France |
Founded | 2013 |
Employees at IPO | 34 |
Website www.abivax.com |